Open and Upcoming Programs – Canada


Open

International Outstanding Achievement Award 2018

Accepting nominations: January 22, 2018
Nomination deadline: June 12, 2018

Rapid Response: Canada 2018

Alzheimer’s & Related Diseases (AD, FTD, MCI, prodromes, and vascular contributions to the listed diseases)

Program opens: February 1, 2018
LOI deadline: April 19, 2018

International Fellowships: Canada 2018

Program opens: February 5, 2018
Application deadline: May 4, 2018

Transformational Research: Canada 2018

Larger, longer grants (up to $1.5m for up to 3 years) for transformational work based on excellent preliminary data.

Program opens: Currently open
Application deadline: February 2018 *DEADLINE EXTENDED*
Award announcement: September 2018

Early Phase Clinical Trials: Canada

Funding (up to $1.5m for up to 4 years) for clinical trials and/or clinical trial sub-studies with excellent preliminary data.

This program accepts applications on a rolling basis. Applicants may submit an LOI at any time and will be notified of whether to prepare a full Proposal within ~2 months of LOI submission. Please refer to the program details for more information.

Postdoctoral Scholars at Oxford

Funding (up to £57,000 per year in salary + benefits, for 2 years) for exceptional Canadian postdoctoral researchers to receive international training at the University of Oxford.

This program accepts applications on a rolling basis, until two positions at a time are filled. All applicants will be notified of the award decision 2 months after their application submission. Please refer to the program details for more information.


Upcoming

Biomarkers against Neurodegenerative Diseases (BAND) 3

Funding for projects that analyze pathogenic similarities and differences across Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. This program enables preliminary pilot research using data and/or samples from large biomarker studies of neurodegenerative disease cohorts, including the Alzheimer’s disease Neuroimaging Initiative (ADNI), the Parkinson’s Progression Markers Initiative (PPMI), and Frontotemporal Lobar Dementia (FTLD).

This program is run in partnership with the Alzheimer’s Association, the Michael J. Fox Foundation, and Alzheimer’s Research UK.

Program opens: Spring 2018

Rapid Response: Canada 2019

Parkinson’s & Related Diseases (PD, PSP, DLB, MSA, prodromes, and vascular contributions to the listed diseases)

Program opens: June 2018

Alzheimer’s & Related Diseases (AD, FTD, MCI, prodromes, and vascular contributions to the listed diseases)

Program opens: To be announced